Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U19AI109680-03
Antiviral Drug Discovery and Development Center - Overall
National Institutes of Health
Grant: 5R01AI108197-08
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
National Institutes of Health
Grant: 5P30CA016086-33
CORE--PROTEOMICS
National Institutes of Health
Grant: 5U54CA156733-04
NCCU-LCCC Partnership in Cancer Research (2 of 2)
National Institutes of Health
Grant: 5R01AI132178-05
Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV
National Institutes of Health
Grant: 5R01AI108197-10
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
National Institutes of Health
Grant: 5U19AI109680-05
Antiviral Drug Discovery and Development Center - Overall
National Institutes of Health
Grant: 5P30ES010126-11
UNC-CH Center for Environmental Health and Suscesptibility
National Institutes of Health
Grant: 5P30CA016086-42
Cancer Center Support Grant
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords
Sustainable Development Goals